Consolidated Edison, Inc. vs GeneDx Holdings Corp — how do they compare? Consolidated Edison, Inc. trades at $111.99 (market cap $40.65B), while GeneDx Holdings Corp trades at $66.34 (market cap $1.96B). The key difference: Consolidated Edison, Inc. is far larger — about 20.7× GeneDx Holdings Corp's market cap, and Consolidated Edison, Inc. pays a 3.15% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| ED | WGS | |
|---|---|---|
Market Cap | $40.65B | $1.96B |
Sector | Utilities | Technology |
52-Week High | $115.46 | $167.51 |
52-Week Low | $95.37 | $34.51 |
Enterprise Value | $67.68B | $1.96B |
Dividend Yield | 3.15% | — |
Trailing returns across standard periods
Latest headlines on both assets
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →